Press release
Vaccine Cold Chain Logistics Market Current Scenario with Future Trends Analysis to 2034
According to the latest market research report the global Vaccine Cold Chain Logistics Market Size is valued at USD 3.5 Billion in 2024 and is predicted to reach USD 5.9 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034.
Request For Free Sample Report:
https://www.insightaceanalytic.com/request-sample/1127
A robust cold chain infrastructure and reliable vaccine distribution networks are critical for preserving the efficacy of vaccines and pharmaceutical products. In the healthcare sector, cold chain logistics plays a vital role in ensuring the temperature-controlled transportation and storage of sensitive medical supplies, such as vaccines, thereby maintaining their quality and safety. Recent advancements in technology have significantly contributed to the innovation and enhancement of vaccine cold chain logistics, supporting more efficient and secure delivery systems.
The growth of the Vaccine cold chain logistics market can be credited to various factors, such as the surging demand for mRNA based Vaccine, increasing need for efficacious cold chain logistics services to maintain the quality of products, high demand for infectious diseases vaccines, growing awareness among people about health & wellness, advancements in the packaging and transportation technologies, rising healthcare expenditure, and increasing R&D investments to develop vaccine storage facilities.
The COVID-19 outbreak has significantly increased the demand for vaccine storage services, and hence, the pharmaceutical companies invested their efforts in developing cold chain logistics. Therefore, the rising R&D initiatives will likely offer new growth opportunities for the vaccine cold chain logistics market in the next few years. However, the high operational costs and the lack of standardized protocols for maintaining cold chain transportation are expected to hinder the market expansion during the forecast years.
Inquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1127
The prominent players in the Vaccine Cold Chain Logistics industry include:
Cryoport (U.S.), DHL Express (Germany), GAC (Dubai), Lynden International Logistics (Canada), PAREXEL (U.S.), United Parcel Service (UPS Healthcare U.S.), DB Schenker (Germany), Yusen Logistics (U.S.), DB Schenker, CEVA Logistics, Q1 Scientific, Marken Ltd., AmeriCold Logistics LLC, FedEx Corporation, Yamato Logistics, and Other Prominent Players.
The increasing investments by players in vaccine development programs, expanding pharmaceutical sector, developing cold supply chain services, and the rising government efforts to establish COVID-19 vaccines will offer promising growth opportunities for the market players operating in the vaccine cold supply chain logistics market.
Key Industry Developments from Leading Players:
• In Octo 2021, Marken, the clinical trial logistics operation with UPS Healthcare (U.S.), expanded its global network to support rising demand for its clinical drug supply chain services, specifically for cell & gene clinical trials.
• In Jul 2021, PAREXEL (U.S.), a leading global biopharmaceutical services provider, merged with EQT IX fund and private business within Goldman Sachs Asset Management for US$8.5 billion based on the company's strong growth trajectory.
• In May 2021, United Parcel Service (U.S.) consolidated all its cold-chain logistics and delivery services into a dedicated global operation that falls under the Atlanta-based company's UPS Healthcare umbrella.
• In Feb 2021, Renergen, South African natural gas and helium producer, started producing helium-powered ultra-cold mobile freezers to store the Covid Vaccine.
Vaccine Cold Chain Logistics Market Regional Analysis: North America majorly contributed to the vaccine cold chain logistics market in 2021 owing to the surging government initiatives for logistics infrastructure and the growing demand for cold chain storages systems. Asia Pacific is expected to witness rapid growth over the forecast period (2022-2030) due to the increasing demand for vaccines, rising R&D investments for pharmaceutical industry developments, and well-developed healthcare infrastructures. Factors such as the technological advancements in the storage and packaging of pharma products, high demand for cold chain systems, and the growing innovations in the pharmaceutical sector have made China a top market for cold chain logistics.
For Customized Information @
https://www.insightaceanalytic.com/customisation/1127
The Global Vaccine Cold Chain Logistics Market Segments
The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 by Services
• Storage
• Packaging
• Transportation
The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 by Packaging Methods
• Dry Ice
• Liquid Nitrogen
• Gel Packs
The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 by Mode of Transportation
• Ground
• Air
• Ocean
The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 by Holding Temperature Range
• Vaccines Requiring Refrigerated Temperature
• Vaccines Requiring Frozen Temperature
• Vaccines Requiring Cryogenic Temperature
The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 by Container
• Active Containers
• Passive Containers
The Global Vaccine Cold Chain Logistics Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2025 to 2034 by Region
• Europe
• North America
• Latin America
• Asia Pacific
• Middle East & Africa
North America Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2025 to 2034
• U.S.
• Canada
Europe Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2025 to 2034
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2025 to 2034
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2025 to 2034
• Brazil
• Mexico
• Rest of Latin America
The Middle East & Africa Vaccine Cold Chain Logistics Market Estimates Revenue (US$ Million) by Country, 2025 to 2034
• GCC Countries
• South Africa
• Rest of the Middle East & Africa
Get More Information :
https://www.insightaceanalytic.com/report/global-vaccine-cold-chain-logistics-market/1127
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vaccine Cold Chain Logistics Market Current Scenario with Future Trends Analysis to 2034 here
News-ID: 4184604 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market- (By Product Type (Combined Nutritional Supplements, Single Nutritional Supplements), By Type Indication (Perimenopause, PMS), By Formulation (Capsules/Tablets, Powder, Softgels, Other), By Sales Channel (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North Ameri …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy CRO Market- (By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by…
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioseparation Systems Market- (By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation and Precipitation), Application (Food, Life Sciences, Pharmaceutical and Biopharmaceutical)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Bioseparation Systems Market is valued at US$…
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc. …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), By Patient Type (Infants, Adults, And Geriatric Populations), Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), End-User (Home Care Settings, Long-Term Care Facilities, And Ambulatory Surgical…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
